Court Rules
All enforcement actions
Enforcement ActionLow RiskMultistate

Coalition of AGs Sues Treasury Over DOGE Unauthorized Data Access

U.S. Department of the TreasuryFebruary 6, 2025Connecticut Attorney General

Summary

Connecticut Attorney General William Tong joined a coalition of 12 attorneys general to announce they will file a lawsuit against the U.S. Department of the Treasury and DOGE for unlawfully granting Elon Musk and DOGE staff access to sensitive personal information and payment systems. The AGs argue this unauthorized access threatens privacy rights and essential payments for millions of Americans. The lawsuit seeks to revoke access and prevent further interference.

Remedy

The attorneys general seek a court order to immediately revoke DOGE's access to Treasury payment systems and personal data, and to enjoin any future unauthorized access or interference with federal payments.

Injunction

Contract Impact

In-house legal teams should review all vendor, customer, and data processing agreements where the company handles federal payment data or sensitive personal information on behalf of the U.S. government. Specifically scrutinize clauses governing data access controls, third-party (including government entity) data sharing, payment system integration, audit rights, and breach notification procedures. Given the allegations of unauthorized access by DOGE staff, contracts must ensure any government data access is strictly limited to authorized personnel under documented legal authority, with robust logging, monitoring, and consent requirements. Amendments may be needed to mandate written authorization for any government data requests, implement tiered access protocols, and require immediate notification of any unauthorized access attempts involving federal systems.

Contract Search Terms

government data access clausesensitive personal information handlingpayment system authorization requirementthird-party access restrictionsunauthorized user prohibitionaudit rights for government datadata retention for federal paymentsbreach notification for Treasury systemsconsent for data disclosure to government entitiesprivacy impact assessment for government contracts

Violation Types

Entity Details

Entity

U.S. Department of the Treasury

Also known as: Treasury

Industry

Other

Multistate Coalition

Official Sources

Source Evidence

Entity Name
"the U.S. Department of the Treasury"
Violation Types
"DOGE has no authority to access this information"

Related Enforcement Actions

NY

U.S. Department of the Treasury

New York Attorney General Letitia James led a coalition of 19 state attorneys general in filing a lawsuit against the Trump administration and U.S. Department of the Treasury over unauthorized access to Americans’ sensitive personal data. The lawsuit alleges the Treasury Department illegally granted Elon Musk and the Department of Government Efficiency (DOGE) access to its central payment system containing bank account details, Social Security numbers, and other private information, violating federal law and the U.S. Constitution. The coalition seeks an injunction to halt the policy and a declaration that the access expansion is unlawful and unconstitutional.

CT

U.S. Department of the Treasury

Connecticut Attorney General William Tong filed a lawsuit against President Trump and the U.S. Treasury Department to stop DOGE's unauthorized access to the Treasury's central payment system, which contains sensitive personal information like bank details and Social Security numbers. The lawsuit seeks an injunction and a declaration that the new policy granting access to Elon Musk and DOGE members is unlawful and jeopardizes data security.

CT

U.S. Food and Drug Administration (FDA)

On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.

CT

Bad actor platforms

Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.

CT

None

Connecticut Attorney General William Tong praised final passage of House Bill 5312, which creates new civil enforcement mechanisms for deepfake digital sexual assault. The legislation allows the AG to pursue civil injunctions and penalties against platforms that disseminate illegal synthetic intimate images, including AI-generated child pornography, and establishes a private right of action for victims. The bill builds on prior Connecticut laws criminalizing unauthorized dissemination of intimate images.

CT

Made-in-China

$300K

Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.